Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial.

Goodyear CS. et al, (2024), The Lancet. Rheumatology, 6, e339 - e351

Role of mucosal-associated invariant T cells in coronavirus disease 2019 vaccine immunogenicity.

Amini A. et al, (2024), Current opinion in virology, 67

A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity

Liu C. et al, (2024), Cell Reports Medicine, 5, 101553 - 101553

Antibody, not Cellular, Immune Responses to SARS-CoV-2 Vaccination Outperform Infection in Inflammatory Bowel Disease Patients.

González Cueto E. et al, (2024), Inflammatory bowel diseases, 30, 859 - 862

Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms

Citarella BW. et al, (2024), Heliyon, 10, e29591 - e29591

Fine needle aspiration of human lymph nodes reveals cell populations and soluble interactors pivotal to immunological priming

Provine NM. et al, (2024), European Journal of Immunology, 54

MAIT cell-MR1 reactivity is highly conserved across multiple divergent species.

Edmans MD. et al, (2024), The Journal of biological chemistry

Multi-omics analysis reveals COVID-19 vaccine induced attenuation of inflammatory responses during breakthrough disease

Drury RE. et al, (2024), Nature Communications, 15

Obesity differs from diabetes mellitus in antibody and T-cell responses post-COVID-19 recovery

Ali M. et al, (2024), Clinical and Experimental Immunology

Southeast Asia initiative to combat SARS-CoV-2 variants (SEACOVARIANTS) consortium

Nhu LNT. et al, (2024), Wellcome Open Research, 9, 181 - 181

Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection.

Liu C. et al, (2024), Nature communications, 15

IL-5 antagonism reverses priming and activation of eosinophils in severe eosinophilic asthma.

Luo J. et al, (2024), Mucosal immunology

Sex differences in post-acute neurological sequelae of SARS-CoV-2 and symptom resolution in adults after coronavirus disease 2019 hospitalization: an international multi-centre prospective observational study

Cho S-M. et al, (2024), Brain Communications, 6

The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86.

Zhou D. et al, (2024), Nature communications, 15

A single cell atlas of frozen shoulder capsule identifies features associated with inflammatory fibrosis resolution.

Ng MTH. et al, (2024), Nature communications, 15

Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study

Elneima O. et al, (2024), International Journal of Epidemiology, 53

Emerging Enterovirus A71 Subgenogroup B5 Causing Severe Hand, Foot, and Mouth Disease, Vietnam, 2023

Chau NVV. et al, (2024), Emerging Infectious Diseases, 30

Demultiplexing of single-cell RNA-sequencing data using interindividual variation in gene expression

Nassiri I. et al, (2024), Bioinformatics Advances, 4

Accelarated immune ageing is associated with COVID-19 disease severity.

Lord JM. et al, (2024), Immunity & ageing : I & A, 21

Effect of second booster vaccinations and prior infection against SARS-CoV-2 in the UK SIREN healthcare worker cohort.

Kirwan PD. et al, (2024), The Lancet regional health. Europe, 36

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?